Evidence map›Paper›PMID 26132720›Full record

ArticleAnesthesiology2015

Antioxidants protect calsequestrin-1 knockout mice from halothane- and heat-induced sudden death.

Antonio Michelucci, Cecilia Paolini, Marta Canato, Lan Wei-Lapierre, Laura Pietrangelo, Alessandro De Marco, Carlo Reggiani, Robert T Dirksen, Feliciano Protasi

Open access · bronzeAbstract read
In one paragraph

Article in Anesthesiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 41 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Cytosolic CaBiophysical reports · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Store-Operated CaInternational journal of molecular sciences · 2022
    Article
  12. Ablation of Calsequestrin-1, CaFrontiers in physiology · 2022
    Review
  13. Review
  14. Article
  15. Article
  16. Altered CaMetabolites · 2021
    Review
  17. Calsequestrin, a key protein in striated muscle health and disease.Journal of muscle research and cell motility · 2021
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 2 countries.

Antonio MichelucciFrom the Center for Research on Ageing and Department of Neuroscience, Imaging and Clinical Sciences, University G. d'Annunzio of Chieti, Chieti, Italy (A.M., C.P., L.P., A.D.M., F.P.); Department of Biomedical Sciences, University of Padova, Padova, Italy (M.C., C.R.); and Department of Pharmacology and Physiology, University of Rochester Medical Center, Rochester, New York (L.W.-L., R.T.D.).
Cecilia Paolini
Marta Canato
Lan Wei-Lapierre
Laura Pietrangelo
Alessandro De Marco
Carlo Reggiani
Robert T Dirksen
Feliciano Protasi
University of Chieti-Pescara · IT

Funding

Basis of Muscle Dysfunction in Malignant Hyperthermia & Central Core DiseaseR01AR053349 · NIAMS · BAYLOR COLLEGE OF MEDICINE · PI DIRKSEN, ROBERT T, HAMILTON, SUSAN L · 2006 to 2020
$8.0M
Molecular Mechanism and Functional Role of SOCE in Skeletal MuscleR01AR059646 · NIAMS · UNIVERSITY OF ROCHESTER · PI DIRKSEN, ROBERT T · 2010 to 2020
$3.6M
NIAMS NIH HHS AR053349NIAMS NIH HHS AR059646NIAMS NIH HHS R01 AR053349NIAMS NIH HHS R01 AR059646PHS HHS MDA275574Telethon GGP13213
6 · The paper itself

Abstract

backgroundMice lacking calsequestrin-1 (CASQ1-null), a Ca-binding protein that modulates the activity of Ca release in the skeletal muscle, exhibit lethal hypermetabolic episodes that resemble malignant hyperthermia in humans when exposed to halothane or heat stress.

methodsBecause oxidative species may play a critical role in malignant hyperthermia crises, we treated CASQ1-null mice with two antioxidants, N-acetylcysteine (NAC, Sigma-Aldrich, Italy; provided ad libitum in drinking water) and (±)-6-hydroxy-2,5,7,8-tetramethylchromane-2-carboxylic acid (Trolox, Sigma-Aldrich; administered by intraperitoneal injection), before exposure to halothane (2%, 1 h) or heat (41°C, 1 h).

resultsNAC and Trolox significantly protected CASQ1-null mice from lethal episodes, with mortality being 79% (n = 14), 25% (n = 16), and 20% (n = 5) during halothane exposure and 86% (n = 21), 29% (n = 21), and 33% (n = 6) during heat stress in untreated, NAC-treated, and Trolox-treated mice, respectively. During heat challenge, an increase in core temperature in CASQ1-null mice (42.3° ± 0.1°C, n=10) was significantly reduced by both NAC and Trolox (40.6° ± 0.3°C, n = 6 and 40.5° ± 0.2°C, n = 6). NAC treatment of CASQ1-null muscles/mice normalized caffeine sensitivity during in vitro contracture tests, Ca transients in single fibers, and significantly reduced the percentage of fibers undergoing rhabdomyolysis (37.6 ± 2.5%, 38/101 fibers in 3 mice; 11.6 ± 1.1%, 21/186 fibers in 5 mice). The protective effect of antioxidant treatment likely resulted from mitigation of oxidative stress, because NAC reduced mitochondrial superoxide production, superoxide dismutase type-1 expression, and 3-nitrotyrosine expression, and increased both reduced glutathione and reduced glutathione/oxidized glutathione ratio.

conclusionThese studies provide a deeper understanding of the mechanisms that underlie hyperthermic crises in CASQ1-deficient muscle and demonstrate that antioxidant pretreatment may prevent them.

Indexed as

Anesthetics, InhalationAnimalsAntioxidantsCalcium-Binding ProteinsCalsequestrinDeath, SuddenHalothaneHot TemperatureMaleMiceMice, KnockoutAnesthetics, InhalationAntioxidantsCalcium-Binding ProteinsCalsequestrinCasq1 protein, mouseHalothane

Identifiers

PMID26132720
PMCPMC4543432
OpenAlexW2120712042

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.